Cedarville U commits to innovating pharmacy practice
The Cedarville University School of Pharmacy opened its new Center for Pharmacy Innovation on Jan. 1, 2018 thanks to a $250,000 donation from Dave and Phyllis Grauer of Dublin, Ohio. In addition to this contribution, the Grauers also serve on the School of Pharmacy’s board of advisors, have taught at the school and have funded scholarships for pharmacy students.
According to Marc Sweeney, dean of the Cedarville University School of Pharmacy, the Grauers’ contribution is meant to spur on others to help support the new center. “Our hope is to identify creative solutions to some of our most challenging problems in health care,” Sweeney said. “With the Grauers’ gift, we hope to attract additional donors who will commit to fostering innovation in pharmacy and healthcare.”
The Center for Pharmacy Innovation employs Justin Cole, assistant professor of pharmacy practice, as director. He works to attract innovators and funding for pilot projects to address issues such as medication non-adherence, rising drug and healthcare costs, appropriate integration of technology and new drug discovery. The Cedarville, Ohio-based center will collaborate with the Ohio Pharmacists Association, among others, to develop creative solutions to healthcare issues.
“We want to help professional pharmacists look for and identify areas in health care where they can play a key role in optimizing quality, reducing costs, and improving population health,” Sweeney said. “Not only are the president and Congress trying to address those issues, but solutions need to come from within the healthcare system as well.”
“Pharmacists can do more with their drug knowledge and communication skills as a member of a team of healthcare professionals to help implement innovative healthcare delivery,” Dave Grauer said.
Teva launches generic of Syprine
Teva has introduced its generic Syprine (trientine hydrochloride) capsules. The drug was included on the Food and Drug Administration’s list of off-patent, off-exclusivity branded drugs that didn’t have generics.
“Teva filed our [abbreviated new drug application] more than two years ago and we are pleased that the FDA has now approved our applications and we are able to offer a lower-cost generic alternative to patients,” Teva executive vice president of global R&D Hafrun Fridriksdottir said. “We look forward to working closely with the FDA on their review of our many other generic applications.”
The drug is indicated to treat patients with Wilson’s disease — a genetic disorder that prevents the body from removing excess copper — who are intolerant of penicillamine. Teva’s generic Syprine will be available in 250-mg dosage strength.
Wilson’s disease is estimated to affect roughly 1-in-30,000 individuals. The drug had U.S. sales of roughly $155 million for the 12 months ended November 2018, according to IQVIA data.
“The launch of trientine hydrochloride capsules illustrates Teva’s commitment to serving patient populations in need—whether it’s a medicine that could be taken by millions of individuals or one focused on a rare condition disorder like Wilson’s disease,” Teava executive vice president and head of North America commercial Brendan O’Grady said.
Upsher-Smith, NASPA honor 45 pharmacists
Upsher-Smith Labs and the National Alliance of State Pharmacy Associations have announced the recipients of the 2017 NASPA Excellence in Innovation award.
The award, sponsored by the Maple Grove, Minn.-based manufacturer and coordinated by NASPA, recognized 45 pharmacists for their contributions to the pharmacy profession. The pharmacists received the award from their state pharmacy associations over the course of 2017.
“Upsher-Smith is proud to be a continued sponsor of NASPA’s Excellence in Innovation Award,” Upsher-Smith president and CEO Rusty Field said. “We are honored to give recognition to these awardees that have demonstrated innovation in the pharmacy profession and advanced patient care. Upsher-Smith shares these values and understands the critical role pharmacy plays in improving the health and lives of patients.”
The award is meant to recognize pharmacists who have shown significant innovation in their practice, method or service that results in improved patient care or advancing the profession of pharmacy.
“We appreciate Upsher-Smith for supporting the Excellence in Innovation Award,” NASPA executive vice president and CEO Rebecca Snead said. “The pharmacists honored have demonstrated exemplary professional achievements and innovation. We are proud to partner with Upsher-Smith and recognize these leaders for their commitment to advancing the pharmacy profession and improving the lives of patients across America every day.”
The pharmacists recognized were:
- Alabama: Patrick Devereux;
- Alaska: Karen Thompson;
- Arizona: Alyssa M. Peckham;
- Arkansas: Jody Smotherman;
- California: Christine Givant;
- Colorado: Paul B. Shaw;
- Connecticut: Ellen Jones;
- Delaware: Stephanie Pro;
- Florida: Damien D. Simmons;
- Georgia: Jennifer Shannon;
- Illinois: Starlin Haydon-Greatting;
- Indiana: Carrie Morton;
- Iowa: Jordan Schultz;
- Kansas: Molly Aldrich;
- Kentucky: Melanie Dicks, Holly Divine and Tera McIntosh;
- Louisiana: Jennifer Boudreaux;
- Maine: Courtney Doherty Oland;
- Maryland: Neil Leikach and Dixie Leikach;
- Massachusetts: Allison E. Burns;
- Michigan: Andrew J. Reeves;
- Minnesota: Anjoli Punjabi;
- Mississippi: Amanda Wilburn;
- Missouri: Stuart D. Federman;
- Montana: Michael F. Bertagnolli;
- New Hampshire: Eric R. Lessard;
- New Jersey: Domenic DiPrimo;
- New Mexico: Brian Hunt;
- New York: Christopher Daly;
- North Carolina: Robert F. Carta;
- North Dakota: Briana D. Fluhrer;
- Ohio: Erin L. Thompson;
- Oklahoma: Travis B. Wolff;
- Pennsylvania: Melissa Somma McGivney;
- Rhode Island: Linda Rowe-Varone;
- South Carolina: Deborah D. Bowers;
- Tennessee: Philip J. Baker;
- Virginia: Tana Kaefer;
- Washington: Monica Graybeal;
- Washington; DC: Carlisha Gentles;
- West Virginia: Jason Turner;
- Wisconsin: Erica Guetzlaff; and
- Wyoming: Shawn Dalton.